All In MedTech

FDA Clearance Tracker · P010014-S005

OXFORD MENISCAL UNICOMPARTMENTAL KNEE SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Aug 3, 2007 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Aug 3, 2007

Approved

Time to decision

640 days

Received Nov 1, 2005. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P010014-S005
Device name
OXFORD MENISCAL UNICOMPARTMENTAL KNEE SYSTEM
Applicant location
Warsaw, IN
Received
Nov 1, 2005
Decided
Aug 3, 2007
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Express GMP Supplement
Original approval
P010014

Device type

Device class
Class III

Every decision under product code NRA

FDA's approval statement

As written in FDA's record.

APPROVAL FOR A STERILIZATION SITE LOCATED AT ISOTRON PLC, BERKSHIRE, UNITED KINGDOM.

Source documents

Other decisions for Biomet Manufacturing Corp

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.